Medical News / Coverage ASRS 2019: Same-Day Treatments Preferred in Patients Receiving Anti-VEGF Therapy

Results of a new study show that receiving same day intravitreal anti-VEGF treatments was highly preferred among patient populations that were disabled, elderly, or traveling long-distance. 
 The study, which was presented at the 2019 American Society of Retina Specialists Annual Meeting, included more than 230 patients and was conducted by investigators from the University of Minnesota. Source: MDmag By reading more or clicking on the link below, you are leaving this site and going to another site run by another organization

read more

Findings of recent research demonstrate an intervention program, Balance after Baby, is promising for decreasing diabetes ... read more
A new analysis of data from the PIONEER program indicates reductions in HbA1c and body weight ... read more
Findings of a recent study suggest empagliflozin is associated with a decreased risk of hospitalization for ... read more
Testosterone treatment may prevent progression to or reverse type 2 diabetes in high-risk men who are ... read more